On October 19, 2026, the Philadelphia Eagles announced that their star quarterback, Jalen Hurts, had been diagnosed with blood clots in his lungs and leg. The news sent shockwaves through the league and among fans who had just witnessed him as a Super Bowl MVP. This diagnosis marks a significant turning point in his career, likely sidelining him for the rest of 2026.
The team stated Monday that Hurts was originally diagnosed with deep vein thrombosis in his left calf. However, further testing revealed bilateral pulmonary emboli. To understand the gravity of this situation, one must consider what these conditions mean. Deep vein thrombosis involves a clot forming in a large vein, typically in the leg. When such a clot breaks loose and travels to the lungs, it becomes a pulmonary embolism, which is a life-threatening blockage. The Eagles confirmed he has been placed on injured reserve following this revelation. They anticipate that he will have no long-term effect once off blood thinners, but the immediate impact is severe.
Following the diagnosis, the timeline shifted dramatically. On October 19, 2026, Tanner McKee started in place of Jalen Hurts. This decision underscores the severity of the injury; Hurts could not return to the field. He has been treated with blood thinners and will not participate in any contact activities during this time. The Eagles indicated that they expect him to make a full recovery when off blood thinners, yet the season is effectively over for him at this moment. This stands in stark contrast to his performance earlier in the year.
Critics pointed to specific incidents involving travel as evidence of poor oversight.
The controversy surrounding this injury stems from the timing of the diagnosis relative to his participation in games. Reports indicate that Jalen Hurts played in a game despite being in the hospital due to blood clots. This led to criticism of the Eagles' decision to allow him to play under those circumstances. His agent stated that he will undergo blood thinners and is expected to recover fully, but the public scrutiny focused heavily on the risk taken. The narrative suggests that allowing an athlete to play while suffering from a condition that requires hospitalization raises serious questions about safety protocols.
Critics pointed to specific incidents involving travel as evidence of poor oversight. Linda Cohn, a prominent voice in the discussion, argued that Hurts should not have been allowed to board that plane to London. She noted that he was complaining about the calf pain and they did nothing initially. Furthermore, she questioned why they waited to get to London before taking the first ultrasound. These details highlight a potential failure in monitoring his symptoms before high-stakes travel. The concern was that if he were already in danger, traveling across the ocean without proper assessment would be negligent.
Public reaction was swift and harsh regarding the medical decisions made. Mike Garafolo expressed strong disapproval of the process. He stated, "That entire Eagles medical staff should be fired!" This sentiment reflects the broader anxiety among observers. The criticism is not just about the injury itself, but about the management of the player's health leading up to the diagnosis. The expectation is that the club will address these concerns, though the focus remains on Hurts' recovery.
As the organization navigates this crisis, the focus remains on the player's health rather than the roster implications alone. The Eagles are aware that Hurts was the MVP of a Super Bowl, which occurred in 2025. His status as a top-tier talent makes the injury particularly sensitive. The team knows that during this time, he will not be allowed to participate in any contact activities, including football. The path forward depends on his ability to clear the blood clots safely. Until then, the team relies on McKee to carry the load. The hope is that the diagnosis does not derail his future, but the immediate reality is a season-ending injury that has already sparked debate about the limits of athletic risk tolerance.
